QUINTARELLI, CONCETTA

QUINTARELLI, CONCETTA  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 83 (tempo di esecuzione: 0.039 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Safely Improving the in Vivo Survival of Tumor Specific Cytotoxic T Lymphocytes by Co-Transfer of IL7 Receptor Alpha Chain and icaspase9 1.5 Abstract in rivista 2008 Vera, J. V.; Hoyos, V.; Savoldo, B.; Quintarelli, Concetta
Gene transfer of IL-7R alpha (IL-7R alpha) on antigen-specific cytotoxic T cells (CTLs) restores their ability to respond to IL-7 cytokine 1.5 Abstract in rivista 2007 Vera, J. F.; Hoyos, V.; Savoldo, B.; Quintarelli, Concetta; Giordano Attianese, G.; Foster, A. E.; Dotti, G.
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients 1.5 Abstract in rivista 2009 Esposito, N.; Quintarelli, Concetta; Colavita, I.; Pane, Fabrizio
Transgenic expression of inducible caspase9 suicide gene for in vivo elimination of antigen specific cytotoxic T cells (CTLs) engineered to produce cytokines. 1.5 Abstract in rivista 2006 Quintarelli, Concetta; Vera, F. V.; Savoldo, B.; B. Giordano, G.; Brenner, M. K.; Dotti, G.
Generation of Epstein Barr Virus Specific Cytotoxic T Lymphocytes (EBV-CTLs) Resistant to the Immunosuppressive Drug Tacrolimus (FK506) 1.5 Abstract in rivista 2009 DE ANGELIS, Biagio; G., Dotti; Quintarelli, Concetta; Le, Huye; L., Zhang; M., Zhang; Heslop, H. E.; Brenner, M. K.; Rooney, C. M.; B. S. a. v. o. l. d., O.
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7 1.1 Articolo in rivista 2009 Vera, Jf; Hoyos, V; Savoldo, B; Quintarelli, Concetta; Giordano Attianese, G; Leen, Am; Liu, H; Foster, Ae; Heslop, He; Rooney, Cm; Brenner, Mk; Dotti, G.
Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib. 1.5 Abstract in rivista 2012 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, Santa; S., Caruso; N., Esposito; L., Luciano; S., Paratore; C., Galimberti; S., Soverini; C., Terragna; D., Cilloni; G., Saglio; G., Martinelli; F., Giles; A., Hochhaus; Pane, Fabrizio
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. 1.1 Articolo in rivista 2013 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio
Induction of PRAME-specific immunity by overlapping pentadecapeptides in patients with hematologic malignancies 1.5 Abstract in rivista 2009 Quintarelli, Concetta; DE ANGELIS, Biagio; G., Dotti; L., Luciano; H., Heslop; C., Rooney; M., Brenner; B., Savoldo; Pane, Fabrizio
Early detection of residual disease by Q-RT-PCR of the hybrid BCR/ABL transcript is a powerful predictor of treatment response in adult Philadelphia - Positive acute lymphoblastic leukemia. 1.5 Abstract in rivista 2003 Pane, Fabrizio; Izzo, Barbara; Quintarelli, Concetta; Camera, A.; Cimino, G.; Vitale, A.; Specchia, G.; Saglio, G.; Foa, R.; Salvatore, F.; Rotoli, B.; Mandelli, F.
Gene therapy to improve function of T cells for adoptive immunotherapy. 1.1 Articolo in rivista 2010 Quintarelli, Concetta; B., Savoldo; G. D. o. t. t., I.
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes. 1.1 Articolo in rivista 2007 Quintarelli, Concetta; Vera, Jf; Savoldo, B; Giordano Attianese, Gmp; Pule, M; Foster, Ae; Heslop, He; Rooney, Cm; Brenner, Mk; Dotti, G.
Spleen is the dark side of essential Thrombocitemia 4.2 Abstract in Atti di convegno 2011 Pugliese, N; Picardi, Marco; Marano, L; Gherghi, Marco; Izzo, Barbara; Ciancia, R; Ciancia, G; Quintarelli, Concetta; Muccioli Casadei, G; Martinelli, V. Pane F.
Transgenic expression of IL15 selectively expands antigen specific cytotoxic T cells (CTLs) enhancing their anti-tumor effect in vivo. 1.5 Abstract in rivista 2006 Quintarelli, Concetta; Savoldo, B.; Giordano, G.; Foster, A.; Pule, M.; Heslop, H.; Rooney, C.; Brenner, M.; Dotti, G.
Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells. 1.5 Abstract in rivista 2003 Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F.
Preferentially expressed antigen of melanoma (PRAME)-specific cytotoxic T-Lymphocytes (CTLs) and transgenic T cells to target chronic myelogenous leukemia (CML) 1.5 Abstract in rivista 2007 Quintarelli, Concetta; . Dotti G, .; De Angelis, B.; Pane, Fabrizio; Savoldo, B.
Polyclonal PRAME-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia 1.5 Abstract in rivista 2008 Quintarelli, Concetta; Dotti, G.; De Angelis, B.; Hoyos, V.; Savoldo, B.
Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy 1.5 Abstract in rivista 2008 Hoyos, V.; Savoldo, B.; Vera, Jf; Quintarelli, Concetta
A small animal in vivo imaging model of expanded vs. unexpanded UCB stem cells reveals differential patterns of engraftment 1.5 Abstract in rivista 2007 Steiner, D.; Robinson, S. N.; Decker, W. K.; Marini, F. C.; Shpall, E. J.; Bollard, C. M.; Quintarelli, Concetta; Dotti, G.
Transition index: new original tool to identify subsets overlapping MPN phenotypes. 4.2 Abstract in Atti di convegno 2011 Marano, L; Gherghi, Marco; Pugliese, N; Madonna, E; Quintarelli, Concetta; Ciancia, R; Ciancia, G; Izzo, Barbara; Muccioli Casadei, G; Martinelli, V; Pane, Fabrizio